The number of patients suffering from overweight and obesity has been steadily increasing in recent years. Obesity is one of the independent risk factors for thromboembolic disease. Treating thrombotic complications in obese patients poses a challenge not only because of the adjustments in anticoagulant dosing but also due to the lack of evidence regarding the safety and efficacy of higher doses of anticoagulants in this growing group of the population.
Don‘t have an account? Create new account
Authors: Prof. MUDr. Jan Kvasnička, DrSc.
Enter the email address that you registered with. We will send you instructions on how to set a new password.
